Home › Funds › Egerton Capital (UK) LLP › MDLN
Egerton Capital (UK) LLP position in MDLN
MEDLINE INC · Health Care
Egerton Capital (UK) LLP reported holding 13,283,017 shares of MDLN (MEDLINE INC) in its Q3 2026 13F filing — a position valued at US$460.9M, representing 4.69% of its reported portfolio and ranking #8 among its reported holdings. Egerton Capital (UK) LLP has disclosed MDLN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Egerton Capital (UK) LLP's MDLN position evolved
Egerton Capital (UK) LLP first disclosed a stake in MDLN in Q1 2026 at 4,365,802 shares (US$194.3M). The position peaked in Q2 2026 at 16,470,884 shares, worth US$649.6M. Across 3 filings, Egerton Capital (UK) LLP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 13,283,017 shares valued at US$460.9M — a reduction of -3,187,867 shares quarter over quarter.. Notable position changes include a 277% increase in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 4.37M | $194.28M | New |
| Q2 2026 | 16.47M | $649.61M | Add |
| Q3 2026 | 13.28M | $460.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDLN and 13F data
MDLN (MEDLINE INC) is a Health Care company. 93 other funds we track also report a position in MDLN — the largest reported positions include Carlyle Group Inc. (US$6.49B), Blackstone Inc. (US$4.01B), H&F Corporate Investors X, Ltd. (US$2.46B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDLN
- Carlyle Group Inc. 187.08M sh · $6.49B · Q3 2026
- Blackstone Inc. 101.79M sh · $4.01B · Q2 2026
- H&F Corporate Investors X, Ltd. 70.87M sh · $2.46B · Q3 2026
- Lone Pine Capital 20.97M sh · $826.99M · Q2 2026
- LONE PINE CAPITAL LLC 20.97M sh · $826.99M · Q2 2026
- SurgoCap Partners LP 7.49M sh · $295.31M · Q2 2026
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 7.36M sh · $290.10M · Q2 2026
- Alyeska Investment Group, L.P. 6.81M sh · $268.55M · Q2 2026
- BANQUE PICTET & CIE SA 7.46M sh · $258.69M · Q3 2026
- Unisphere Establishment 3.68M sh · $145.24M · Q2 2026
- SEVEN GRAND MANAGERS, LLC 3.65M sh · $144.00M · Q2 2026
- Ghisallo Capital Management LLC 3.00M sh · $118.32M · Q2 2026
More on Egerton Capital (UK) LLP
FAQ
How long has Egerton Capital (UK) LLP held MDLN?
Egerton Capital (UK) LLP has disclosed MDLN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Egerton Capital (UK) LLP's current position in MDLN?
As of Q3 2026, Egerton Capital (UK) LLP holds 13.28M shares of MDLN (MEDLINE INC), valued at $460.92M, representing 4.69% of its reported portfolio and ranking #8.
Has Egerton Capital (UK) LLP been buying or selling MDLN?
In the latest 13F filing (Q3 2026), Egerton Capital (UK) LLP reduced its position in MDLN. The position peaked in Q2 2026 at 16.47M shares.
Which other funds hold MDLN?
Other major institutional holders of MDLN include Carlyle Group Inc., Blackstone Inc., H&F Corporate Investors X, Ltd., among 93 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.